## Core Concept
Post-exposure prophylaxis (PEP) is an emergency medication taken after potential exposure to HIV to prevent infection. The goal is to provide antiretroviral therapy within 72 hours of exposure to be effective. The regimen typically involves a combination of antiretroviral drugs.

## Why the Correct Answer is Right
The correct regimen for post-exposure prophylaxis (PEP) usually consists of a combination of three drugs: two nucleoside reverse transcriptase inhibitors (NRTIs) plus a third drug from a different class, such as a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (PI), or an integrase strand transfer inhibitor (INSTI). The combination helps to effectively suppress the virus during the window period before it establishes a permanent infection. Among the given options, option effectively covers the necessary classes of antiretroviral drugs for PEP.

## Why Each Wrong Option is Incorrect
- **Option A:** This option might not provide a full combination of drugs necessary for effective PEP, potentially lacking a crucial class of antiretroviral medication.
- **Option B:** Similarly, this might not offer the complete coverage needed, possibly missing a key component that helps prevent the virus from integrating into the host's DNA or replicating.
- **Option D:** This could be inadequate due to the absence of a critical drug class, making it less effective in preventing HIV infection post-exposure.

## Clinical Pearl / High-Yield Fact
A critical aspect of PEP is timely initiation; it should ideally start within 2 hours of exposure and no more than 72 hours. The recommended regimen often includes emtricitabine/tenofovir (a fixed-dose NRTI combination) plus a third agent like raltegravir (an INSTI) or dolutegravir, which are preferred for their efficacy and safety profiles.

## Correct Answer Line
**Correct Answer: .**